In the context of glutamine depletion or inhibition of glutamine transport, in conjunction with ICD-inducing chemotherapeutic agents, a synergistic activation of IFN-β occurs, leading to CD8 T-cell recruitment and an inhibition of cancer cell growth via the OTUD4/LDHA axis [97]. This evidence concerns the gene CD8A and cancer.